[HTML][HTML] Enzyme therapy: current challenges and future perspectives

M de la Fuente, L Lombardero… - International Journal of …, 2021 - mdpi.com
In recent years, enzymes have risen as promising therapeutic tools for different pathologies,
from metabolic deficiencies, such as fibrosis conditions, ocular pathologies or joint …

[HTML][HTML] Endotheliopathy in acute COVID-19 and long COVID

AG Vassiliou, CS Vrettou, C Keskinidou… - International Journal of …, 2023 - mdpi.com
The pulmonary endothelium is a highly regulated organ that performs a wide range of
functions under physiological and pathological conditions. Since endothelial dysfunction …

The pivotal link between ACE2 deficiency and SARS-CoV-2 infection: one year later

F Angeli, M Zappa, G Reboldi, M Trapasso… - European journal of …, 2021 - Elsevier
The pandemic caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-
2) generated much interest on the basic pathogenetic mechanisms through which SARS …

[HTML][HTML] An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019 …

CA Devaux, L Camoin-Jau - Frontiers in microbiology, 2022 - frontiersin.org
It has been known for many years that the angiotensin-converting enzyme 2 (ACE2) is a cell
surface enzyme involved in the regulation of blood pressure. More recently, it was proven …

[HTML][HTML] Soluble angiotensin converting enzyme 2 (ACE2) is upregulated and soluble endothelial nitric oxide synthase (eNOS) is downregulated in COVID-19-induced …

AG Vassiliou, A Zacharis, C Keskinidou, E Jahaj… - Pharmaceuticals, 2021 - mdpi.com
A damaged endothelium is an underlying condition of the many complications of COVID-19
patients. The increased mortality risk associated with diseases that have underlying …

[HTML][HTML] SARS-CoV-2 and the host-immune response

DP Maison, Y Deng, M Gerschenson - Frontiers in Immunology, 2023 - frontiersin.org
The SARS-CoV-2 pandemic and the COVID-19 disease have affected everyone globally,
leading to one of recorded history's most significant research surges. As our knowledge …

[HTML][HTML] Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles

C Wu, Q Xu, H Wang, B Tu, J Zeng, P Zhao… - … Pharmaceutica Sinica B, 2022 - Elsevier
The spread of coronavirus disease 2019 (COVID-19) throughout the world has resulted in
stressful healthcare burdens and global health crises. Developing an effective measure to …

Renin angiotensin aldosterone system in pulmonary fibrosis: Pathogenesis to therapeutic possibilities

D Gupta, A Kumar, A Mandloi, V Shenoy - Pharmacological Research, 2021 - Elsevier
Pulmonary fibrosis is a devastating lung disease with multifactorial etiology characterized by
alveolar injury, fibroblast proliferation and excessive deposition of extracellular matrix …

[HTML][HTML] S protein, ACE2 and host cell proteases in SARS-CoV-2 cell entry and infectivity; is soluble ACE2 a two blade sword? A narrative review

R Nejat, MF Torshizi, DJ Najafi - Vaccines, 2023 - mdpi.com
Since the spread of the deadly virus SARS-CoV-2 in late 2019, researchers have restlessly
sought to unravel how the virus enters the host cells. Some proteins on each side of the …

Counter-regulatory renin-angiotensin system in hypertension: Review and update in the era of COVID-19 pandemic

H Chen, J Peng, T Wang, J Wen, S Chen… - Biochemical …, 2023 - Elsevier
Cardiovascular disease is the major cause of mortality and disability, with hypertension
being the most prevalent risk factor. Excessive activation of the renin-angiotensin system …